Boron-Containing Mesoporous Silica Nanoparticles with Effective Delivery and Targeting of Liver Cancer Cells for Boron Neutron Capture Therapy
ACS Applied Materials & Interfaces · 2024
DOI: 10.1021/acsami.4c02897 ↗At a glance
Journal article in ACS Applied Materials & Interfaces, 2024. Written by Hongyu Tang and 23 co-authors. Institution: School of Pharmacy, China Medical University, Shenyang 110122, China. Major MEDLINE topics: Boron Neutron Capture Therapy, Silicon Dioxide, Nanoparticles, Liver Neoplasms. Cited 6 times so far (Crossref); 51 references. Funded by: National Key Research and Development Program of China, Basic and Applied Basic Research Foundation of Guangdong Province, Institute of High Energy Physics, Chinese Academy of Sciences.
Abstract (original language)
Nanocarriers have been researched comprehensively for the development of novel boron-containing agents in boron neutron capture therapy (BNCT). We designed and synthesized a multifunctional mesoporous silica nanoparticle (MSN)-based boron-containing agent. The latter was coated with a lipid bilayer (LB) and decorated with SP94 peptide (SFSIIHTPILPL) on the surface as SP94-LB@BA-MSN. The latter incorporated boric acid (BA) into hydrophobic mesopores, coated with an LB, and modified with SP94 peptide on the LB. SP94-LB@BA-MSN enhanced nano interface tumor-targeting ability but also prevented the premature release of drugs, which is crucial for BNCT because adequate boron content in tumor sites is required. SP94-LB@BA-MSN showed excellent efficacy in the BNCT treatment of HepG-2 cells. In animal studies with tumor-bearing mice, SP94-LB@BA-MSN exhibited a satisfactory accumulation at the tumor site. The boron content reached 40.18 ± 5.41 ppm in the tumor site 4 h after injection, which was 8.12 and 15.51 times higher than those in mice treated with boronated phenylalanine and those treated with BA. For boron, the tumor-to-normal tissue ratio was 4.41 ± 1.13 and the tumor-to-blood ratio was 5.92 ± 0.45. These results indicated that nanoparticles delivered boron to the tumor site effectively while minimizing accumulation in normal tissues. In conclusion, this composite (SP94-LB@BA-MSN) shows great promise as a boron-containing delivery agent for the treatment of hepatocellular carcinoma using BNCT. These findings highlight the potential of MSNs in the field of BNCT.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Pharmacy, China Medical University, Shenyang 110122, China.
- CAS Key Laboratory for Biomedical Effects of Nanomaterial and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences (CAS), Beijing 100049, China.
ORCID profiles: Hongyu Tang, Mengyao Li, Kui Chen, Ya-Nan Chang, Meng Wang, Xuesong Feng, Juan Li
Funding
- National Key Research and Development Program of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- Institute of High Energy Physics, Chinese Academy of Sciences
- Beijing Science and Technology Planning Project
Cite
APA
Tang, H., Wang, Z., Hao, H., Luo, W., Yang, J., Li, M., Yang, M., Chen, Z., Yan, R., Li, H., Hu, F., Liang, H., Liu, Q., Lv, L., Zhang, J., Su, W., Chen, R., Chen, K., Chang, Y. N., …, & Xing, G. (2024). Boron-Containing Mesoporous Silica Nanoparticles with Effective Delivery and Targeting of Liver Cancer Cells for Boron Neutron Capture Therapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c02897
Vancouver
Tang H, Wang Z, Hao H, Luo W, Yang J, Li M, et al. Boron-Containing Mesoporous Silica Nanoparticles with Effective Delivery and Targeting of Liver Cancer Cells for Boron Neutron Capture Therapy. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c02897
BibTeX
@article{Tang2024,
author = {Tang, Hongyu and Wang, Zhijie and Hao, Haoyang and Luo, Weixian and Yang, Jingru and Li, Mengyao and Yang, Mingxin and Chen, Ziteng and Yan, Ruyu and Li, Hao and Hu, Fan and Liang, Haojun and Liu, Qiuyang and Lv, Linwen and Zhang, Junhui and Su, Wenxi and Chen, Ranran and Chen, Kui and Chang, Ya-Nan and Wang, Meng and Zheng, Lingna and Feng, Xuesong and Li, Juan and Xing, Gengmei},
title = {Boron-Containing Mesoporous Silica Nanoparticles with Effective Delivery and Targeting of Liver Cancer Cells for Boron Neutron Capture Therapy},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
doi = {10.1021/acsami.4c02897}
}
EUVIMED